C. Ripa

608 total citations
16 papers, 442 citations indexed

About

C. Ripa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, C. Ripa has authored 16 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in C. Ripa's work include Occupational and environmental lung diseases (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Pleural and Pulmonary Diseases (3 papers). C. Ripa is often cited by papers focused on Occupational and environmental lung diseases (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Pleural and Pulmonary Diseases (3 papers). C. Ripa collaborates with scholars based in Italy, Malaysia and United Kingdom. C. Ripa's co-authors include Giovanni Luca Ceresoli, Maurilio Ponzoni, Eugenio Villa, Eugênio Bucci, Armando Santoro, Laura Giordano, Paolo Andrea Zucali, Elena Lorenzi, Fabio De Vincenzo and Letizia Gianoncelli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

C. Ripa

13 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Ripa Italy	5	208	204	146	121	63	16	442
Efrosyni Sfakianaki United States	7	52 0.3×	255 1.3×	34 0.2×	53 0.4×	204 3.2×	12	344
Shervin V. Oskouei United States	10	36 0.2×	194 1.0×	95 0.7×	39 0.3×	107 1.7×	19	290
Daniel Chen United States	5	204 1.0×	71 0.3×	138 0.9×	19 0.2×	66 1.0×	8	280
Mahmut Nedim Aytekin Türkiye	8	38 0.2×	138 0.7×	77 0.5×	36 0.3×	59 0.9×	30	266
Harika Tirumani United States	10	81 0.4×	208 1.0×	88 0.6×	35 0.3×	59 0.9×	22	303
T. Krausz United Kingdom	5	153 0.7×	56 0.3×	108 0.7×	29 0.2×	50 0.8×	8	292
Olivier Bayle France	8	38 0.2×	79 0.4×	59 0.4×	71 0.6×	29 0.5×	18	300
Servando Cardona Germany	5	123 0.6×	216 1.1×	39 0.3×	27 0.2×	110 1.7×	6	294
G Kullmann Norway	6	32 0.2×	107 0.5×	114 0.8×	39 0.3×	64 1.0×	9	304
Melissa Vos Netherlands	9	56 0.3×	190 0.9×	51 0.3×	37 0.3×	68 1.1×	15	246

Countries citing papers authored by C. Ripa

Since Specialization

Citations

This map shows the geographic impact of C. Ripa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ripa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ripa more than expected).

Fields of papers citing papers by C. Ripa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Ripa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ripa. The network helps show where C. Ripa may publish in the future.

Co-authorship network of co-authors of C. Ripa

This figure shows the co-authorship network connecting the top 25 collaborators of C. Ripa. A scholar is included among the top collaborators of C. Ripa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Ripa. C. Ripa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Bonomi, Maria, et al.. (2017). Intermittent maintenance treatment with bevacizumab in patients with metastatic colorectal cancer: A single centre experience.. Journal of Clinical Oncology. 35(4_suppl). 776–776.

Bonomi, Maria, Lucia Bonomi, Anna Bettini, et al.. (2016). Uncommon epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer and sensitivity to EGFR tyrosine kinase inhibitors, a two centers experience. Annals of Oncology. 27. iv9–iv9. 1 indexed citations

Ceresoli, Giovanni Luca, Federica Grosso, Paolo Andrea Zucali, et al.. (2014). Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey. British Journal of Cancer. 111(2). 220–226. 29 indexed citations

Ercilla, M.G., et al.. (2014). PS-050 Inhaled sodium colistimethate-associated thrombocytopenia. A case report. European Journal of Hospital Pharmacy. 21(Suppl 1). A164.1–A164.

Ceresoli, Giovanni Luca, Paolo Andrea Zucali, Manlio Mencoboni, et al.. (2013). Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma. British Journal of Cancer. 109(3). 552–558. 68 indexed citations

Ripa, C., et al.. (2012). Prevalence of dysphagia in the older using ‘Eating Assessment Tool-10’. European Journal of Hospital Pharmacy. 19(2). 205.2–206. 4 indexed citations

Ripa, C., et al.. (2012). Evaluation of malnutrition and vitamin D levels in an older medical unit. European Journal of Hospital Pharmacy. 19(2). 212.1–212. 1 indexed citations

Ceresoli, Giovanni Luca, Paolo Andrea Zucali, Fabio De Vincenzo, et al.. (2011). Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma. Lung Cancer. 72(1). 73–77. 90 indexed citations

Lorenzi, Elena, Letizia Gianoncelli, Paolo Andrea Zucali, et al.. (2010). Vinorelbine (V) in pemetrexed-pretreated patients (PTS) with malignant pleural mesothelioma (MPM).. Journal of Clinical Oncology. 28(15_suppl). 7041–7041. 1 indexed citations

10.

Tarantino, Luciano, et al.. (2009). Lenograstim in the treatment of severe neutropenia in patients treated with Peg-IFN and ribavirin: the experience of a single hepatology unit.. PubMed. 17(1). 20–3. 2 indexed citations

11.

Ripa, C., et al.. (2008). P241 VALIDATION OF A MALNUTRITION SCREENING TOOL USEFUL IN A GENERAL HOSPITAL. Clinical Nutrition Supplements. 3. 132–132. 1 indexed citations

12.

Siracusano, Licia, Monica Balzarotti, Massimo Magagnoli, et al.. (2004). FluCyD combination in low-grade lymphomas: An active regimen for selected patients. 7(3). 357–362. 1 indexed citations

13.

Balzarotti, Monica, Michele Spina, Barbara Sarina, et al.. (2002). Intensified CHOP regimen in aggressive lymphomas:maximal dose intensity and dose density of doxorubicin and cyclophosphamide. Annals of Oncology. 13(9). 1341–1346. 23 indexed citations

14.

Ripa, C., et al.. (2001). [Metastatic breast cancer: what are the objectives?].. PubMed. 86(5 Suppl 1). S22–8. 2 indexed citations

15.

Ripa, C., et al.. (2000). Il Carcinoma Metastatico Della Mammella: Quali Obiettivi?. Tumori Journal. 86(5_suppl1). 22–28. 2 indexed citations

16.

Ceresoli, Giovanni Luca, et al.. (1997). Primary cardiac lymphoma in immunocompetent patients. Cancer. 80(8). 1497–1506. 217 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact